Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy

Detalles Bibliográficos
Autores principales: Chin, K., Chand, V. K., Nuyten, D. S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Industry Corner: Perspectives and Controversies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834034/
https://www.ncbi.nlm.nih.gov/pubmed/28407031
http://dx.doi.org/10.1093/annonc/mdx170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834034/
https://www.ncbi.nlm.nih.gov/pubmed/28407031
http://dx.doi.org/10.1093/annonc/mdx170

Ejemplares similares